Prostate Cancer Treatments Seen Shifting Toward Focused Therapies
This article was originally published in The Gray Sheet
Executive Summary
Newly available options for the treatment of prostate cancer are likely to shift the clinical focus away from the entire gland toward focused therapies for the tumor, Varian Medical Systems President and CEO Richard Levy, PhD, told attendees of the Innovative Solutions for Prostate Cancer Care conference on June 5 in Washington D.C.